儿童瘤组的2023年研究蓝图:骨瘤
Damon R Reed1, Patrick Grohar2, Elyssa Rubin3
1Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, Florida, USA.
Pediatric blood & cancer
|July 28, 2023
概括
儿童瘤组的试验促进了骨髓瘤和尤文瘤的治疗. 新的研究确定了像循环瘤DNA这样的生物标志物对不良结果,指导未来的向治疗和国际合作.
科学领域:
- 儿科瘤学 儿科瘤学
- 整形瘤学 整形瘤学
- 癌症基因组学 癌症基因组学
背景情况:
- 儿童瘤组 (COG) 骨瘤委员会领导针对局部化,转移性和复发性骨髓瘤和尤文瘤 (EWS) 的研究.
- 最近的临床试验已经建立了针对局部骨髓瘤和EWS的国际标准化疗方案.
- 了解疾病生物学方面的进步已经确定了预后不佳的子组.
研究的目的:
- 总结最近在骨肉瘤临床试验和生物研究方面的进展和正在进行的研究.
- 要突出与骨髓瘤和EWS中不良结果相关的新生物标志物的识别.
- 概述未来的方向,包括有针对性的治疗和国际合作.
主要方法:
- 在过去十年中,对已完成的临床试验和已发表的结果进行分析.
- 识别和验证生物特征和基因组变化 (例如ctDNA,MYC放大,STAG2/TP53突变) 作为预后生物标志物.
- 启动新的临床试验,评估激酶抑制剂和局部管理策略.
主要成果:
- 已确立的国际化疗标准治疗局部骨髓瘤和EWS.
- 确定了循环瘤DNA (ctDNA),MYC放大 (骨肉瘤) 和STAG2/TP53突变 (EWS) 作为潜在的不良结果生物标志物.
- 目前正在进行的试验正在调查向疗法和改进的局部治疗方法.
结论:
- 最近的COG研究显著改善了骨肉瘤的护理标准.
- 生物标志物发现 (ctDNA,基因组改变) 为风险分层和个性化治疗提供了新的途径.
- 国际合作对于推进罕见骨肉瘤研究至关重要.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


